1 terminated, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow Mitos Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain 7% (w/v) Tempol alcohol-based gel (MTS-01), alcohol-based gel - Alopecia | Phase 2 | Unknown | Mitos Pharmaceuticals | 16 | 2008-11-01 | 2008-12-03 |
| Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy MTS-01, Placebo - Alopecia | Phase 2 | Terminated | Mitos Pharmaceuticals | 16 | 2007-04-01 | 2008-07-11 |
Alopecia (2)
United States (1)
James Metz, MD (1)